Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Abstract

Development of a photoaffinity ligand for octopamine receptors.

J A Nathanson
Molecular Pharmacology July 1989, 36 (1) 34-43;
J A Nathanson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Octapamine receptors are widely distributed in invertebrate species, yet little is known about their biochemical structure or tissue localization, in part because there exist no high affinity or irreversible ligands for these receptors. This paper characterizes 2-(2,6-diethyl-4-azidophenylimino)imidazolidine (NC-5Z), a new, high affinity octopamine receptor probe that binds reversibly and, under photolyzing conditions, irreversibly to membrane-associated octopamine receptors. Under reversible conditions NC-5Z is a full agonist, 50-100 times more potent than octopamine in activating the highly enriched and specific octopamine-sensitive adenylate cyclase of the firefly light organ. NC-5Z shows a similar potency in cockroach muscle and thoracic ganglia and in tobacco hornworm nerve cord. Activation of light organ adenylate cyclase by NC-5Z is nonadditive to that caused by octopamine and can be blocked by antagonists, including mainserin (Ki = 0.9 microM), cyproheptadine (Ki = 5 microM), phentolamine (Ki = 20 microM), and propranolol (Ki = 75 microM). These constants agree well with those for the same antagonists in inhibiting stimulation due to octopamine. In physiological studies, NC-5Z mimics the action of, but is more potent than, octopamine in stimulating light emission in intact firefly tails and in disrupting motor behavior and feeding of tobacco hornworms. Under reversible conditions, [3H]NC-5Z, the tritiated derivative of NC-5Z, binds to light organ membranes with an apparent affinity (0.59-0.7 microM) similar to that (0.35-0.7 microM) for NC-5Z in activating adenylate cyclase. Under photolyzing conditions, NC-5Z irreversibly activates light organ adenylate cyclase, and this can be blocked by an excess of octopamine. Under similar conditions, [3H]NC-5Z binds irreversibly to light organ membranes and to membranes from tobacco hornworm nerve ganglia, fat body, and gut. This binding is reduced by prior incubation with octopamine agonists, including octopamine, demethyl-chlordimeform, and 2-(phenylimino)imidazolidines, but not by norepinephrine, dopamine, serotonin, or histamine. Irreversible binding is also reduced by prior incubation with antagonists, most effectively (55% of total binding) by mianserin. The apparent affinity of [3H]NC-5Z for membrane binding, as reflected by its ability to be displaced by mianserin, is altered by GTP. In autoradiographic studies of whole tissue, [3H]NC-5Z shows irreversible, mianserin-displaceable labeling of intact firefly light organs. Taken together, these data indicate that NC-5Z and [3H]NC-5Z are potent and selective agonists of octopamine receptors in a variety of tissues.(ABSTRACT TRUNCATED AT 400 WORDS)

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 36, Issue 1
1 Jul 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Development of a photoaffinity ligand for octopamine receptors.
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

Development of a photoaffinity ligand for octopamine receptors.

J A Nathanson
Molecular Pharmacology July 1, 1989, 36 (1) 34-43;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

Development of a photoaffinity ligand for octopamine receptors.

J A Nathanson
Molecular Pharmacology July 1, 1989, 36 (1) 34-43;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics